Organic Letters
Letter
Wiley-VCH, 2011; p 221. (d) Talele, T. T. J. Med. Chem. 2016, 59,
(20) A series of 3/4 mixtures in variable ratio (1:1−9:1) were
treated with TsOH (10 mol %) in toluene and afforded the
Information). Again, cyclopropylcarbaldehyde 3s underwent sponta-
8
712.
3) Triggle, D. J.; Mitchell, J. M.; Filler, R. CNS Drug Rev. 1998, 4,
7.
4) Zhu, W.; Bao, X.; Ren, H.; Da, Y.; Wu, D.; Li, F.; Yan, Y.; Wang,
L.; Chen, Z. Eur. J. Med. Chem. 2016, 115, 161.
5) Anthes, R.; Benoit, S.; Chen, C.-K.; Corbett, E. A.; Corbett, R.
(
8
(
neous ring expansion to 4s in CDCl
.
3
(21) Paquette, L. A.; Hofferberth, J. E. Org. React. 2003, 62, 477.
1
8
(
(22) This mechanism was investigated using labeled O-1a, which
upon reaction with 2a in the presence of the acid catalyst afforded
M.; DelMonte, A. J.; Gingras, S.; Livingston, R. C.; Pendri, Y.;
Sausker, J.; Soumeillant, M. Org. Process Res. Dev. 2008, 12, 178.
1
8
18
O-3a in 92% yield (>75% O incorporation).
(
6) Denya, I.; Malan, S. F.; Enogieru, A. B.; Omoruyi, S. I.; Ekpo, O.
E.; Kapp, E.; Zindo, F. T.; Joubert, J. MedChemComm 2018, 9, 357.
7) (a) Foote, K. M.; Blades, K.; Cronin, A.; Fillery, S.; Guichard, S.
(23) (a) Conia, J. M.; Salaun, J. Acc. Chem. Res. 1972, 5, 33.
(b) Barnier, J. P.; Denis, J. M.; Salaun, J.; Conia, J. M. Tetrahedron
1974, 30, 1397. (c) Gembus, V.; Karmazin, L.; Pira, S.; Uguen, D.
Bull. Chem. Soc. Jpn. 2018, 91, 319.
(
S.; Hassall, L.; Hickson, I.; Jacq, X.; Jewsbury, P. J.; McGuire, T. M.;
Nissink, J. W. M.; Odedra, R.; Page, K.; Perkins, P.; Suleman, A.;
Tam, K.; Thommes, P.; Broadhurst, R.; Wood, C. J. Med. Chem. 2013,
(
24) Attempts to promote a C3−C4 enantioselective ring expansion
of carbaldehydes 3a and 3r using a chiral phosphoric acid such as (R)-
TRIP or TiPSY or a chiral sulfonic acid like CSA were unsuccessful,
and cyclobutanones 4a and 4r were isolated as racemic mixtures.
5
6, 2125. (b) Kanada, R.; Tanabe, M.; Muromoto, R.; Sato, Y.;
Kuwahara, T.; Fukuda, H.; Arisawa, M.; Matsuda, T.; Watanabe, M.;
Shuto, S. J. Org. Chem. 2018, 83, 7672.
(
8) Bogus, S. K.; Kuzmin, V. S.; Abramochkin, D. V.; Suzdalev, K. F.;
Galenko-Yaroshevsky, P. A. J. Pharmacol. Sci. 2017, 133, 122.
9) Fink, S. L.; Vojtech, L.; Wagoner, J.; Slivinski, N. S. J.; Jackson,
(
K. J.; Wang, R.; Khadka, S.; Luthra, P.; Basler, C. F.; Polyak, S. J. Sci.
Rep. 2018, 8, 8989.
(
10) Hassam, M.; Basson, A. E.; Liotta, D. C.; Morris, L.; van
Otterlo, W. A. L.; Pelly, S. C. ACS Med. Chem. Lett. 2012, 3, 470.
11) Bell, M. G.; Gernert, D. L.; Grese, T. A.; Belvo, M. D.;
(
Borromeo, P. S.; Kelley, S. A.; Kennedy, J. H.; Kolis, S. P.; Lander, P.
A.; Richey, R.; Sharp, V. S.; Stephenson, G. A.; Williams, J. D.; Yu, H.;
Zimmerman, K. M.; Steinberg, M. I.; Jadhav, P. K. J. Med. Chem.
2
(
007, 50, 6443.
12) Mattson, R.; Denhart, D.; Deskus, J.; Ditta, J.; Marcin, L.;
Epperson, J.; Catt, J.; King, D.; Higgins, M. Preparation of
cyclopropylindoles as selective serotonin reuptake inhibitors. PCT
Int. Appl. WO 0279152, 2002.
(
13) Sampson, P. B.; Liu, Y.; Forrest, B.; Cumming, G.; Li, S.-W.;
Patel, N. K.; Edwards, L.; Laufer, R.; Feher, M.; Ban, F.; Awrey, D. E.;
Mao, G.; Plotnikova, O.; Hodgson, R.; Beletskaya, I.; Mason, J. M.;
Luo, X.; Nadeem, V.; Wei, X.; Kiarash, R.; Madeira, B.; Huang, P.;
Mak, T. W.; Pan, G.; Pauls, H. W. J. Med. Chem. 2015, 58, 147.
(
14) (a) Ebner, C.; Carreira, E. M. Chem. Rev. 2017, 117, 11651.
b) Wasserman, H. H.; Dion, R. P.; Fukuyama, J. Tetrahedron 1989,
5, 3203. (c) Avullala, T.; Asgari, P.; Hua, Y.; Bokka, A.; Ridlen, S. G.;
(
4
Yum, K.; Dias, H. V. R.; Jeon, J. ACS Catal. 2019, 9, 402. (d) Horwell,
D. C.; McKiernan, M. J.; Osborne, S. Tetrahedron Lett. 1998, 39,
8
729. (e) Tsotinis, A.; Vlachou, M.; Papahatjis, D. P.;
Calogeropoulou, T.; Nikas, S. P.; Garratt, P. J.; Piccio, V.; Vonhoff,
S.; Davidson, K.; Teh, M.-T.; Sugden, D. J. Med. Chem. 2006, 49,
3
509. (f) Limbach, M.; Dalai, S.; Janssen, A.; Es-Sayed, M.; Magull, J.;
de Meijere, A. Eur. J. Org. Chem. 2005, 2005, 610. (g) Papahatjis, D.
P.; Nikas, S.; Tsotinis, A.; Vlachou, M.; Makriyannis, A. Chem. Lett.
2
(
001, 30, 192.
15) Porcu, S.; Luridiana, A.; Martis, A.; Frongia, A.; Sarais, G.;
Aitken, D. J.; Boddaert, T.; Guillot, R.; Secci, F. Chem. Commun.
018, 54, 13547.
16) (a) Porcu, S.; Demuro, S.; Luridiana, A.; Cocco, A.; Frongia, A.;
2
(
Aitken, D. J.; Charnay-Pouget, F.; Guillot, R.; Sarais, G.; Secci, F. Org.
Lett. 2018, 20, 7699. (b) Martis, A.; Luridiana, A.; Frongia, A.; Arca,
M.; Sarais, G.; Aitken, D. J.; Guillot, R.; Secci, F. Org. Biomol. Chem.
2017, 15, 10053. (c) Ghisu, L.; Melis, N.; Secci, F.; Caboni, P.; Arca,
M.; Guillot, R.; Boddaert, T.; Aitken, D. J.; Frongia, A. Org. Biomol.
Chem. 2017, 15, 9779. (d) Melis, N.; Secci, F.; Boddaert, T.; Aitken,
D. J.; Frongia, A. Chem. Commun. 2015, 51, 15272.
(
17) Christ, P.; Lindsay, A. G.; Vormittag, S. S.; Neudo
̈
rfl, J.-M.;
Berkessel, A.; O’Donoghue, A. C. Chem. - Eur. J. 2011, 17, 8524.
(
(
18) Bandini, M. Org. Biomol. Chem. 2013, 11, 5206.
19) 4-Ethyl-2,2-bis(1H-indol-3-yl)-1-methylcyclobutanol was iso-
D
Org. Lett. XXXX, XXX, XXX−XXX